MedTrace Logo

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

NCT04181463 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2026-04-23

No results posted yet for this study

Summary

The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.

Conditions

  • Malignant Neoplasm

Interventions

DRUG

Isopropyl Alcohol

Given via nasal inhalation

OTHER

Placebo

Given via nasal inhalation

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Yvonne J Heung · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-11-05
Primary Completion
2028-12-30
Completion
2028-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04181463 on ClinicalTrials.gov